Ease of Access to Medication, Treatment and Diagnosis Unveiled by PEPID at HIMSS13
Patient reference to help patients and institutions manage health and meet Obamacare objectives
Phoenix, AZ — March 4 , 2013 — As members of the healthcare informatics community attend HIMSS13, PEPID will unveil clinical decision support for patients and healthcare professionals providing ease of access to medication, treatment and diagnosis. This will provide all healthcare institutions the immediate availability to meet the meaningful use 2 mandate for patients.
As today’s patients become proactive in managing their own health, and providers spend more time with patients to find effective ways to manage and maintain health, it’s become imperative to make authoritative information easily available. Recognizing this need, the government has mandated that healthcare systems make key information accessible to patients in order to receive funding as part of Meaningful Use 2 objectives.
“Our new PEPID for Patients, made available via Infobutton will provides clinicians and patients instant access content-specific resources and meet Meaningful Use 2 objectives,” says John Wagner, PEPID president. “I’m proud this content-specific is readily available and can be easily implemented into any healthcare system in the world.”
With Obamacare and the American Reinvestment and Recovery Act (ARRA) making big waves in healthcare and electronic medical records, PEPID has given hospitals and healthcare institutions a way to easily provide relevant information to patients and help patients better manage their own health. PEPID for Patients is easily integrated into any patient portal, via any electronic medical record (EMR) system, achieving meaningful use 2 objectives.
In order to find critical information on medications, potential drug interactions, current problem list or to identify a pill, a patient will simply need to login to the healthcare provider’s system or patient portal, and the information will be available to them with the touch of a button. For instance, if a patient has been diagnosed with diabetes type II, he or she will be able to see the diagnosis as well as an “Infobutton” to click and learn more about their disease, lab tests and results, medications and more. If a patient needs to identify a pill, he or she can simply input the shape, color and any markings into the PEPID for Patients module to see potential matches.
The new PEPID for Patients offers a complete reference guide for patients. It contains important information on lab results, procedures, as well as information on managing chronic health conditions. All the information in PEPID for Patients is available via the Infobutton to instantly provide clinicians or patients with access to thousands of content-specific resources, drug reference, lab results, and more to meet Meaningful Use 2 objectives. All information in PEPID for Patients is HL7 (Health Level Seven) compliant.
PEPID for Patients also offers information on drug-to-drug and drug-to-food interactions that’s designed to educate patients about potential interactions that may occur between their medications, supplements and foods they are currently taking. To assist patients in identifying their medication, PEPID also offers the highest-resolution pill pictures and a pill identifier.
Those attending HIMSS March 3-7, 2013 in New Orleans are encouraged to stop by PEPID’s booth #4837 to see a demonstration.
PEPID has provided clinical specialty-focused products since 1994, and offers the most robust medical information resources on the market as well as the best customer service in the industry. Visit www.pepid.com for more information.
Contact: Jenna Reynolds
Phone: (847) 491-9100 x211
Email: press@pepid.com
About PEPID LLC
PEPID utilizes cutting-edge technology to deliver clinical decision-support resources specific for healthcare professionals including pharmacists, doctors, nurses, EMTs and students.
PEPID content is reviewed and contributed to by partners including the American Academy of Emergency Medicine, the National Association of Emergency Medical Services Educators, the Family Physician Inquiries Network, the National Association of Clinical Nurse Specialists, the Oncology Nursing Society, and the American Society of Health-System Pharmacists to ensure content is of the highest quality. Learn more at www.pepid.com, follow us on Twitter (@PEPID_LLC), or become a PEPID fan on Facebook.
Tags:
